Is $2,500? Unstoppable Medical Juggernaut for 20 Years
A rising demand for care and resilient cash flow could make a top medical devices firm a lasting anchor for a long-te...
An accessible primer on stock index levels, detailing what they represent, how they’re calculated, and why they matter for portfolio assessment.
20,792 articlesA rising demand for care and resilient cash flow could make a top medical devices firm a lasting anchor for a long-te...
SpaceX shares declined about 7% after the Federal Reserve kept rates steady, ending a brief three-day rally since its...
Two chipmakers with different playbooks face the 2026 market. This guide breaks down Marvell Technology and Semtech, ...
A major federal loan initiative aims to revitalize nuclear power by backing five new projects with $17.5 billion. Thi...
Comcast plans a two‑unit split, separating media operations from connectivity services. Investors responded with a 24...
The AI boom relies on more than chips. It hinges on the invisible backbone—equipment that enables chipmakers to scale...
Could Energy Transfer (ET) outpace the broad market in the second half of 2026? This article builds a practical, data...
On Thursday, a wave of fresh analyst calls hit Wall Street, lifting some growth names and trimming others as traders ...
A hypothetical $10,000 investment in Lockheed Martin at the Iran conflict’s start would be down about 22% by late Apr...
Netflix just posted a record quarterly revenue, but the forecast for the next quarter came in softer than expected. H...
As markets navigate early-2026 volatility, three dividend-focused ETFs stand out for beginners. Low fees, broad diver...
Intel's shares have surged about 90% in the past year, but the real test lies in whether this comeback can endure thr...